Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin

Cancer Research

Volumn 61, Issue 14, 2001, Pages 5587-5594

  Isogai, Chiho ^a   Laug, Walter E ^a   Shimada, Hiroyuki ^a   Declerck, Paul J ^b   Stins, Monique F ^a   Durden, Donald L ^a   Erdreich Epstein, Anat ^a   DeClerck, Yves A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; FIBRONECTIN; MATRIGEL; PLASMINOGEN ACTIVATOR INHIBITOR 1; VITRONECTIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BRAIN CELL; CANCER GROWTH; CANCER PATIENT; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION;

APOPTOSIS; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FIBRONECTINS; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRINS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECOMBINANT PROTEINS; VITRONECTIN;

EID: 0035878864     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients
2. Plasminogen activator inhibitor-1 is an independent poor prognostic factor for survival in advanced stage epithelial ovarian cancer patients
3. Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis
4. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
5. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration
6. The somatomedin B domain of vitronectin. Structural requirements for the binding and stabilization of active type 1 plasminogen activator inhibitor
7. Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?
8. 3 binding to vitronectin
9. Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation
10. The plasminogen-plasminogen activator (PA) system in neuroblastoma: Role of PA inhibitor-1 in metastasis
11. Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation
12. 5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide
13. Selective expression of adhesion molecules on human brain microvascular endothelial cells
14. 3 for angiogenesis
15. Integrins and anoikis
16. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
17. 3 blocks human breast cancer growth and angiogenesis in human skin
18. Kinetic analysis of integrin-dependent cell adhesion on vitronectin. The inhibitory potential of plasminogen activator inhibitor-1 and RGD peptides
19. Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc
20. Pooled analysis of uPA and PAI- 1 for prognosis in primary breast cancer patients
21. Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for primary breast cancer and following first relapse
22. Immunohistochemical localization of the plasminogen activator inhibitor-1 in breast cancer
23. Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin
24. Fibronectin promotes the elongation of microvessels during angiogenesis in vitro
25. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin
26. Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis
27. Inhibition of angiogenesis in vivo by plasminogen activator inhibitor-1
28. PAI-1 gene expression is regionally induced in wounded epithelial cell monolayers and required for injury repair
29. The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion